Nimodipine plasma concentration and retinal blood flow in healthy subjects

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 8, 2006, Pages 3479-3486

  Michelson, Georg ^a,c   Wärntges, Simone ^a   Leidig, Steffen ^a   Lötsch, Jörn ^b   Geisslinger, Gerd ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; NIMODIPINE; PLACEBO; CALCIUM CHANNEL BLOCKING AGENT; VASODILATOR AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RETINA BLOOD FLOW; TANDEM MASS SPECTROMETRY; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAOCULAR PRESSURE; MASS FRAGMENTOGRAPHY; MICROCIRCULATION; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD VESSEL;

ADMINISTRATION, ORAL; ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; NIMODIPINE; RETINAL VESSELS; VASODILATOR AGENTS;

EID: 33748093982     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1350     Document Type: Article

References (44)

1. + entry blockers. Surv Ophthalmol. 1999;43(suppl 1):S214-S222.
2. Harper AM, Craigen L, Kazda S. Effect of the calcium antagonist, nimodipine, on cerebral blood flow and metabolism in the primate. J Cereb Blood Flow Metab. 1981;1:349-356.
3. Stange K, Lagerkranser M, Sollevi A. Nimodipine does not affect the cerebral autoregulatory response in the anesthetized pig. J Neurosurg Anesthesiol. 1994;6:116-121.
4. Infeld B, Davis SM, Donnan GA, et al. Nimodipine and perfusion changes after stroke. Stroke. 1999;30:1417-1423.
5. Boehm AG, Breidenbach KA, Pillunat LE, Bernd AS, Mueller MF, Koeller AU. Visual function and perfusion of the optic nerve head after application of centrally acting calcium-channel blockers. Graefes Arch Clin Exp Ophthalmol. 2003;241:34-38.
6. Michalk F, Michelson G, Harazny J, Werner U, Daniel WG, Werner D. Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma. J Glaucoma. 2004;13:158-162.
7. Drance SM, Sweeny VP, Morgan RW, Feldmann F. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 1973;89:457-465.
8. Winder AF. Circulating lipoprotein and blood glucose levels in association with low-tension and chronic simple glaucoma. Br J Ophthalmol. 1977;61:641-645.
9. Goldberg I, Hollows FC, Kass MA, Becker B. Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol. 1981;65:56-62.
10. Wax MB, Tezel G, Saito I, et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal pressure glaucoma. Am J Ophthalmol. 1998;125:145-157.
11. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. Invest Ophthalmol Vis Sci. 19985;26:1105-1108.
12. Gasser P, Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma. Am J Ophthalml. 1991;111:585-588.
13. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol. 1998;82:862-870.
14. Michelson G, Zinser G, Schmauss B, inventors. Verfahren und Gerät zur Messung der Fliessgeschwindigkeit, insbesondere des Blutes. Assignee: Heidelberg Engineering GmbH, Heidelberg, Germany. European patent 94108430.3. June 1, 1994.
15. Michelson G, Welzenbach J, Pal I, Harazny J. Automatic full field analysis of analysis of perfusion images gained by scanning laser Doppler flowmetry. Br J Ophthalmol. 1998;82:1294-1300.
16. Michelson G, Groh M, Langhans M, Schmauss B. Zweidimensionale Kartierung der retinalen und papillären Mikrozirkulation mittels Scanning-Laser -Doppler-Flowmetrie. Klin Monatsbl Augenheilkunde. 1995;207:180-190.
17. Michelson G, Schmauss B. Two-dimensional mapping of the juxtapapillary perfusion by scanning laser Doppler flowmetry. Br J Ophthalmol. 1995;79:1126-1132.
18. Michelson G, Schmauss B, Langhans MJ, Harazny J, Groh MJM. Principle, validity, and reliability of scanning laser Doppler flowmetry. J Glaucoma. 1996;5:99-105.
19. 2. Br J Ophthalmol. 1997;81:360-364.
20. Chauhan B. Confocal scanning laser Doppler flowmetry of the retina and optic nerve head. In: Anderson DR, Drance SM, eds. Encounters in Glaucoma Research, 3: How to Ascertain Progression and Outcome. Amsterdam: Kugler; 1996:263-276.
21. Chauhan B, Smith FM. Confocal scanning laser Doppler flowmetry: experiments in a model flow system. J Glaucoma. 1997;6:237-245.
22. Bonner RF, Nossal R. Principles of laser-Doppler flowmetry. In: Sheperd AP, Öberg PA, eds. Laser Doppler Blood Flowmetry. Vol 107. Boston: Kluwer; 1990:17-45.
23. Riva-Rocci S. Un nuovo sfigmomanometro [A new sphygmomanometer]. Gazzetta Medica di Torino. 1896;50:981-996.
24. Haws CW, Gourley JK, Heistad DD. Effects of nimodipine on cerebral blood flow. J Pharmacol Exp Ther. 1983;225:24-28.
25. Mohamed AA, Mendelow AD, Teasdale GM, Harper AM, McCulloch J. Effect of the calcium antagonist nimodipine on local cerebral blood flow and metabolic coupling. J Cereb Blood Flow Metab. 1985;5:26-33.
26. Mohamed AA, McCulloch J, Mendelow AD, Teasdale GM, Harper AM. Effect of the calcium antagonist nimodipine on local cerebral blood flow: relationship to arterial blood pressure. J Cereb Blood Flow Metab. 1984;4:206-211.
27. Kawaguchi K, Henshall DC, Simon RP. Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia. Eur J Pharmacol. 1999;364:99-105.
28. Pierre LN, Davenport AP, Katusic ZS. Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke. 1999;30:638-643
29. Piltz-Seymour JR, Grunwald JE, Hariprasad SM, Dupont J. Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol. 2001;132:63-69.
30. Prunte C, Orgul S, Flammer J. Abnormalities of microcirculation in glaucoma: facts and hints. Curr Opin Ophthalmol. 1998;9:50-55.
31. Pillunat LE. Ocular blood flow endpoints. Eur J Ophthalmol. 1999;9(suppl 1):S44-S47.
32. Nimotop [Fachinformation zu]. Aulendorf, Germany: Bayer AG; July 1994.
33. Nimodipine [investigator's brochure]. Wuppertal, Germany: Bayer AG, BG Pharma; December 1993.
34. Luksch A, Rainer G, Koyuncu D, et al. Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. Br J Ophthalmol. 2005;89:21-25.
35. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma. 1998;7:372-377.
36. Piltz JR, Bose S, Lanchoney D. The effect of nimodipine, a centrally active calcium antagonist, on visual function and macular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma. 1998;7:336-342.
37. Bose S, Piltz JR, Breton ME. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects. Ophthalmology. 1995;102:1236-1241.
38. Wilson RP, Chang WJ, Sergott RC, et al. A color Doppler analysis of nifedipine-induced posterior ocular blood flow changes in open-angle glaucoma. J Glaucoma. 1997;6:231-236.
39. Harris A, Evans DW, Cantor LB, Martin B. Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma. Am J Ophthalmol. 1997;124:296-302.
40. Yamamoto T, Niwa Y, Kawakami H, Kitazawa Y. The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma. J Glaucoma. 1998;7:301-305.
41. Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996;103:283-288.
42. Alborch E, Salom JB, Torregrosa G. Calcium channels in cerebral arteries. Pharmacol Ther. 1995;68:1-34.
43. Netland PA, Grosskreutz CL, Feke GT, Hart LJ. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker. Am J Ophthalmol. 1995;119:694-700.
44. Yu DY, Townsend R, Cringle SJ, Chauhan BC, Morgan WH. Improved interpretation of flow maps obtained by scanning laser Doppler flowmetry using a rat model of retinal artery occlusion. Invest Ophthalmol Vis Sci. 2005;46:166-174.